Penumbra, Inc. (NYSE:PEN) management will conduct a conference call for 28th October 2020 at 4:30 PM Eastern Time to discuss financial results and companys performance for 3Q20.
The conference call will also be available live on the website www.penumbrainc.com
Earnings Expectation
Penumbra, Inc. is set to announce third quarter earning results on Wednesday 28th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, PEN to report 3Q20 loss of $ 0.08 per share. For the full year, analysts anticipate top line of $ 516.87 million, while looking forward to loss of $ 0.27 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 635.00 million ~ $ 645.00 million
Click Here For More Historical Outlooks Of Penumbra, Inc.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, Japan, and internationally. The company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, and PX SLIM brands; and aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the JET, ACE and 3D Revascularization Device brands.
